市場調査レポート

商品コード

1561028

インターベンショナルオンコロジーの世界市場規模、シェア、成長分析、製品タイプ別、がんタイプ別、手技別、地域別 - 産業予測、2024年～2031年

Global Interventional Oncology Market Size, Share, Growth Analysis, By Product, By Cancer Type, By Procedure, By Region - Industry Forecast 2024-2031

出版日: 2024年09月19日
発行: SkyQuest
ページ情報: 英文 242 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 779,047円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 911,338円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,043,629円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
目次

概要

サンプル依頼リストに入れる

インターベンショナルオンコロジーの世界の世界市場規模は、2022年に21億7,000万米ドルと評価され、2023年の23億1,000万米ドルから2031年には39億2,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは6.8％で成長する見通しです。

インターベンショナルオンコロジーの世界市場セグメンテーションは、主に低侵襲がん治療の進歩に牽引され、より広範ながん領域の中で急速に成長している分野です。この専門分野では、切除、塞栓、放射線治療などの画像誘導手技を用いてがん腫瘍を治療します。世界のがん罹患率の上昇と、より低侵襲な治療オプションに対する需要の高まりが相まって、市場を押し上げています。従来の手術よりもインターベンショナルオンコロジーの世界による治療を選択する患者やヘルスケアプロバイダーが増えるにつれ、市場は大きな成長を遂げています。より優れた画像技術やより精密な器具などの技術革新が、これらの治療効果をさらに高めています。

市場概要
塞栓デバイス
- 放射線塞栓剤
- 非放射性塞栓剤
- マイクロスフィア
- コーティングビーズ
- 微粒子
アブレーション装置
- 高周波（RF）アブレーション装置
- マイクロ波アブレーション装置
- 凍結アブレーション装置
- その他のアブレーション装置
サポートデバイス

インターベンショナルオンコロジーの世界市場：がんタイプ別

市場概要
肝臓がん
腎臓がん
乳がん
肺がん
骨がん
前立腺がん
その他のがん

インターベンショナルオンコロジーの世界市場：手技別

市場概要
経カテーテル動脈放射線塞栓術/選択的内部放射線療法（Tare/Sirt）
経カテーテル動脈化学塞栓術（TACE）
熱腫瘍アブレーション
経カテーテル動脈塞栓術/ブランド塞栓術（TAE）
非熱的腫瘍アブレーション

インターベンショナルオンコロジーの世界市場：エンドユーザー別

市場概要
病院
外来手術センター
研究・学術機関

インターベンショナルオンコロジーの世界市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Boston Scientific Corporation
Medtronic Plc（Ireland）
Johnson & Johnson（US）
Terumo Corporation（Japan）
Merit Medical Systems, Inc.（US）
Teleflex, Inc.（US）
Angiodynamics, Inc.（US）
Becton, Dickinson And Company（US）
Healthtronics, Inc.（US）
Trod Medical（Belgium）
Sanarus Technologies, Inc.（US）
Imbiotechnologies Ltd.（Canada）
Medwaves, Inc.（US）
Icecure Medical（Israel）
Cook Medical（US）
Profound Medical Corp.（Canada）
Sirtex Medical（Australia）
Baylis Medical Company, Inc.（Canada）
Accuray（US）
Alpinion Medical Systems（South Korea）

Product Code: SQMIG35G2238

Global Interventional Oncology Market size was valued at USD 2.17 billion in 2022 and is poised to grow from USD 2.31 billion in 2023 to USD 3.92 billion by 2031, growing at a CAGR of 6.8% in the forecast period (2024-2031).

Interventional Oncology Market is a rapidly growing segment within the broader oncology landscape, primarily driven by advancements in minimally invasive cancer treatments. This specialized field involves the use of image-guided procedures such as ablation, embolization, and radiotherapy to treat cancerous tumors. The rising global cancer burden, coupled with the increasing demand for less invasive treatment options, is pushing the market forward. As more patients and healthcare providers opt for interventional oncology procedures over traditional surgery, the market is witnessing significant growth. Technological innovations, such as better imaging techniques and more precise instruments, are further enhancing the effectiveness of these treatments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Interventional Oncology Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Interventional Oncology Market Segmental Analysis

Global Interventional Oncology Market is segmented on the basis of product, cancer type, procedure, end user, and region. By product, the market is segmented into Embolization Devices, Ablation Devices, and Support Devices. By Cancer Type, the market is segmented into Liver Cancer, Kidney Cancer, Breast Cancer, Lung Cancer, Bone Cancer, Prostate Cancer, and Other Cancers. By procedure, the market is segmented into Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy (TARE/SIRT), Transcatheter Arterial Chemoembolization (TACE), Thermal Tumor Ablation, and Transcatheter Arterial Embolization/Bland Embolization (TAE). By end-user, the market is segmented into hospitals, ambulatory surgery centers, and research & academic institutes. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Interventional Oncology Market

One of the primary drivers of the interventional oncology market is the rising global prevalence of cancer. With an aging population and increasing exposure to risk factors like tobacco use, obesity, and environmental pollutants, cancer rates continue to soar worldwide. According to the World Health Organization (WHO), there are over 19 million new cancer cases annually, leading to increased demand for advanced treatment options like interventional oncology. This method offers a minimally invasive alternative to traditional surgeries, making it more appealing for patients with inoperable or metastatic tumors. Additionally, as survival rates improve with early diagnosis, more patients are opting for less invasive procedures. This rise in cancer cases, along with the growing awareness of interventional oncology's benefits, is accelerating the market's growth trajectory.

Restraints in the Interventional Oncology Market

A significant restraint for the interventional oncology market is the high cost of treatment, particularly in developing regions. Although the procedures are minimally invasive and often more patient-friendly, the technologies and devices used-such as advanced imaging systems and specialized instruments-are expensive. The costs associated with training healthcare professionals and maintaining high-quality equipment further increase the financial burden. In regions with underdeveloped healthcare infrastructure, the adoption of interventional oncology is slower due to these high costs. Moreover, the lack of reimbursement policies for such advanced treatments in many countries further limits their accessibility, hampering market growth in cost-sensitive regions.

Market Trends of the Interventional Oncology Market

A prominent trend in the interventional oncology market is the growing use of image-guided therapies. Technologies like computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound are being integrated into oncology treatments to offer more precision in targeting tumors. These image-guided procedures allow for real-time visualization, reducing the chances of damaging healthy tissues and improving treatment outcomes. The use of robotic-assisted systems for these therapies is also on the rise, as they offer higher accuracy and reduced recovery times. This trend is expected to continue as advancements in imaging technology make these procedures safer, more effective, and accessible to a broader patient population.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Value Chain Analysis
Pricing Analysis

Interventional Oncology Market, By Product

Market Overview
Embolization Devices
- Radioembolic Agents
- Non-Radioactive Embolic Agents
- Microspheres
- Coated Beads
- Microparticles
Ablation Devices
- Radiofrequency (Rf) Ablation Devices
- Microwave Ablation Devices
- Cryoablation Devices
- Other Ablation Devices
Support Devices

Interventional Oncology Market, By Cancer Type

Market Overview
Liver Cancer
Kidney Cancer
Breast Cancer
Lung Cancer
Bone Cancer
Prostate Cancer
Other Cancers

Interventional Oncology Market, By Procedure

Market Overview
Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy (Tare/Sirt)
Transcatheter Arterial Chemoembolization (Tace)
Thermal Tumor Ablation
Transcatheter Arterial Embolization/Bland Embolization (Tae)
Non-Thermal Tumor Ablation

Interventional Oncology Market, By End User

Market Overview
Hospitals
Ambulatory Surgery Centers
Research & Academic Institutes

Interventional Oncology Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic Plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Angiodynamics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson And Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Healthtronics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trod Medical (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanarus Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Imbiotechnologies Ltd. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medwaves, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Icecure Medical (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Profound Medical Corp. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sirtex Medical (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baylis Medical Company, Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Accuray (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alpinion Medical Systems (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments